Evidence map›Paper›PMID 24280223›Full record

ArticleThe Journal of biological chemistry2014

Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α.

Jason Y Jiang, Mulpuri Nagaraju, Rebecca C Meyer, Li Zhang, Donald Hamelberg, Randy A Hall, Edward M Brown, P Jeffrey Conn, Jenny J Yang

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Molecular regulation of calcium-sensing receptor (CaSR)-mediated signaling.Chronic diseases and translational medicine · 2024
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jason Y JiangFrom the Department of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia 30303.
Mulpuri Nagaraju
Rebecca C Meyer
Li Zhang
Donald Hamelberg
Randy A Hall
Edward M Brown
P Jeffrey Conn
Jenny J Yang

Funding

REGULATION OF SIGNALING BY MGLUR5R01MH062646 · NIMH · VANDERBILT UNIVERSITY · PI P Jeffrey Conn, COLLEEN M NISWENDER · 2001 to 2026
$10.9M
Functions of Metabotropic Glutamate Receptor SubtypesR37NS031373 · NINDS · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2014 to 2020
$3.5M
PDZ scaffold regulation of astrocytic glutamate receptors and transportersR01NS055179 · NINDS · EMORY UNIVERSITY · PI HALL, RANDY A. · 2008 to 2012
$1.5M
Ca2+-Sensing Receptor: Novel Roles in Calcium HomeostasisR01DK078331 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BROWN, EDWARD M · 2008 to 2011
$1.4M
Structural Biology of receptor-mediated extracellular calcium signalingR01GM081749 · NIGMS · GEORGIA STATE UNIVERSITY · PI YANG, JENNY J. · 2007 to 2011
$1.2M
NIDDK NIH HHS DK078331NIDDK NIH HHS R01 DK078331NIGMS NIH HHS GM081749-01NIGMS NIH HHS R01 GM081749NIMH NIH HHS R01 MH062646NINDS NIH HHS NS055179NINDS NIH HHS R01 NS055179NINDS NIH HHS R37 NS031373
6 · The paper itself

Abstract

Metabotropic glutamate receptor 1α (mGluR1α), a member of the family C G protein-coupled receptors, is emerging as a potential drug target for various disorders, including chronic neuronal degenerative diseases. In addition to being activated by glutamate, mGluR1α is also modulated by extracellular Ca(2+). However, the underlying mechanism is unknown. Moreover, it has long been challenging to develop receptor-specific agonists due to homologies within the mGluR family, and the Ca(2+)-binding site(s) on mGluR1α may provide an opportunity for receptor-selective targeting by therapeutics. In the present study, we show that our previously predicted Ca(2+)-binding site in the hinge region of mGluR1α is adjacent to the site where orthosteric agonists and antagonists bind on the extracellular domain of the receptor. Moreover, we found that extracellular Ca(2+) enhanced mGluR1α-mediated intracellular Ca(2+) responses evoked by the orthosteric agonist l-quisqualate. Conversely, extracellular Ca(2+) diminished the inhibitory effect of the mGluR1α orthosteric antagonist (S)-α-methyl-4-carboxyphenylglycine. In addition, selective positive (Ro 67-4853) and negative (7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester) allosteric modulators of mGluR1α potentiated and inhibited responses to extracellular Ca(2+), respectively, in a manner similar to their effects on the response of mGluR1α to glutamate. Mutations at residues predicted to be involved in Ca(2+) binding, including E325I, had significant effects on the modulation of responses to the orthosteric agonist l-quisqualate and the allosteric modulator Ro 67-4853 by extracellular Ca(2+). These studies reveal that binding of extracellular Ca(2+) to the predicted Ca(2+)-binding site in the extracellular domain of mGluR1α modulates not only glutamate-evoked signaling but also the actions of both orthosteric ligands and allosteric modulators on mGluR1α.

Indexed as

Allosteric RegulationAmino Acid SubstitutionBenzoatesBinding SitesCalciumCalcium SignalingCarbamatesExcitatory Amino Acid AgonistsGlycineHEK293 CellsHumansMutation, MissenseProtein Structure, TertiaryQuisqualic AcidReceptors, Metabotropic GlutamateXanthenes(9H-xanthene-9-carbonyl)carbamic acid butyl esteralpha-methyl-4-carboxyphenylglycineBenzoatesCalciumCarbamatesExcitatory Amino Acid AgonistsGlycinemetabotropic glutamate receptor type 1Quisqualic AcidReceptors, Metabotropic GlutamateXanthenesAllosteric ModulatorsCalciumCalcium-binding ProteinsDrug DiscoveryGlutamate Receptors MetabotropicG Protein-coupled Receptors (GPCR)Orthosteric AgonistOrthosteric Antagonist

Identifiers

PMID24280223
PMCPMC3894344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.